Morgan Stanley Maintains Overweight on Definitive Healthcare, Lowers Price Target to $9.5
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Craig Hettenbach has maintained an Overweight rating on Definitive Healthcare (NASDAQ:DH), but lowered the price target from $15.5 to $9.5.
November 03, 2023 | 12:48 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Morgan Stanley has maintained an Overweight rating on Definitive Healthcare but lowered the price target from $15.5 to $9.5.
The lowering of the price target by Morgan Stanley could lead to a negative sentiment among investors, potentially causing a short-term decrease in the stock price of Definitive Healthcare.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100